Global Long-Acting Injectable (LAI) Antipsychotic Market Growth (Status and Outlook) 2026-2032
The global Long-Acting Injectable (LAI) Antipsychotic market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Long-acting injectable (LAI) antipsychotics are a pharmacologic strategy for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Long-Acting Injectable (LAI) Antipsychotic Industry Forecast” looks at past sales and reviews total world Long-Acting Injectable (LAI) Antipsychotic sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-Acting Injectable (LAI) Antipsychotic sales for 2026 through 2032. With Long-Acting Injectable (LAI) Antipsychotic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-Acting Injectable (LAI) Antipsychotic industry.
This Insight Report provides a comprehensive analysis of the global Long-Acting Injectable (LAI) Antipsychotic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long-Acting Injectable (LAI) Antipsychotic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-Acting Injectable (LAI) Antipsychotic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-Acting Injectable (LAI) Antipsychotic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-Acting Injectable (LAI) Antipsychotic.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-Acting Injectable (LAI) Antipsychotic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Long-acting injectable (LAI) antipsychotics are a pharmacologic strategy for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Long-Acting Injectable (LAI) Antipsychotic Industry Forecast” looks at past sales and reviews total world Long-Acting Injectable (LAI) Antipsychotic sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-Acting Injectable (LAI) Antipsychotic sales for 2026 through 2032. With Long-Acting Injectable (LAI) Antipsychotic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-Acting Injectable (LAI) Antipsychotic industry.
This Insight Report provides a comprehensive analysis of the global Long-Acting Injectable (LAI) Antipsychotic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Long-Acting Injectable (LAI) Antipsychotic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-Acting Injectable (LAI) Antipsychotic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-Acting Injectable (LAI) Antipsychotic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-Acting Injectable (LAI) Antipsychotic.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-Acting Injectable (LAI) Antipsychotic market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Aripiprazole
- Fluphenazine
- Haloperidol
- Others
- Hospital
- Retail Pharmacy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alkermes
- Eli Lilly and Company
- Janssen Global Services, LLC
- Abilify Maintena
- Haldol
- Otsuka Pharmaceutical
- Aristada
- Prolixin
- Sumitomo Dainippon Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Size (2021-2032)
2.1.2 Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Long-Acting Injectable (LAI) Antipsychotic by Country/Region (2021, 2025 & 2032)
2.2 Long-Acting Injectable (LAI) Antipsychotic Segment by Type
2.2.1 Aripiprazole
2.2.2 Fluphenazine
2.2.3 Haloperidol
2.2.4 Others
2.2.5 Long-Acting Injectable (LAI) Antipsychotic Market Size by Type
2.2.5.1 Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
2.3 Long-Acting Injectable (LAI) Antipsychotic Segment by Application
2.3.1 Hospital
2.3.2 Retail Pharmacy
2.3.3 Others
2.3.4 Long-Acting Injectable (LAI) Antipsychotic Market Size by Application
2.3.4.1 Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
3 LONG-ACTING INJECTABLE (LAI) ANTIPSYCHOTIC MARKET SIZE BY PLAYER
3.1 Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Player
3.1.1 Global Long-Acting Injectable (LAI) Antipsychotic Revenue by Player (2021-2026)
3.1.2 Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Player (2021-2026)
3.2 Global Long-Acting Injectable (LAI) Antipsychotic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LONG-ACTING INJECTABLE (LAI) ANTIPSYCHOTIC BY REGION
4.1 Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2021-2026)
4.2 Global Long-Acting Injectable (LAI) Antipsychotic Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-Acting Injectable (LAI) Antipsychotic Market Size Growth (2021-2026)
4.4 APAC Long-Acting Injectable (LAI) Antipsychotic Market Size Growth (2021-2026)
4.5 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Growth (2021-2026)
4.6 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2021-2026)
5.2 Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026)
5.3 Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2021-2026)
6.2 APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026)
6.3 APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2021-2026)
7.2 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026)
7.3 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic by Region (2021-2026)
8.2 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026)
8.3 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LONG-ACTING INJECTABLE (LAI) ANTIPSYCHOTIC MARKET FORECAST
10.1 Global Long-Acting Injectable (LAI) Antipsychotic Forecast by Region (2027-2032)
10.1.1 Global Long-Acting Injectable (LAI) Antipsychotic Forecast by Region (2027-2032)
10.1.2 Americas Long-Acting Injectable (LAI) Antipsychotic Forecast
10.1.3 APAC Long-Acting Injectable (LAI) Antipsychotic Forecast
10.1.4 Europe Long-Acting Injectable (LAI) Antipsychotic Forecast
10.1.5 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Forecast
10.2 Americas Long-Acting Injectable (LAI) Antipsychotic Forecast by Country (2027-2032)
10.2.1 United States Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.2.2 Canada Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.2.3 Mexico Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.2.4 Brazil Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.3 APAC Long-Acting Injectable (LAI) Antipsychotic Forecast by Region (2027-2032)
10.3.1 China Long-Acting Injectable (LAI) Antipsychotic Market Forecast
10.3.2 Japan Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.3.3 Korea Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.3.4 Southeast Asia Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.3.5 India Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.3.6 Australia Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.4 Europe Long-Acting Injectable (LAI) Antipsychotic Forecast by Country (2027-2032)
10.4.1 Germany Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.4.2 France Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.4.3 UK Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.4.4 Italy Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.4.5 Russia Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.5 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Forecast by Region (2027-2032)
10.5.1 Egypt Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.5.2 South Africa Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.5.3 Israel Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.5.4 Turkey Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.6 Global Long-Acting Injectable (LAI) Antipsychotic Forecast by Type (2027-2032)
10.7 Global Long-Acting Injectable (LAI) Antipsychotic Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Long-Acting Injectable (LAI) Antipsychotic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Alkermes
11.1.1 Alkermes Company Information
11.1.2 Alkermes Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.1.3 Alkermes Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Alkermes Main Business Overview
11.1.5 Alkermes Latest Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Information
11.2.2 Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.2.3 Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Eli Lilly and Company Main Business Overview
11.2.5 Eli Lilly and Company Latest Developments
11.3 Janssen Global Services, LLC
11.3.1 Janssen Global Services, LLC Company Information
11.3.2 Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.3.3 Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Janssen Global Services, LLC Main Business Overview
11.3.5 Janssen Global Services, LLC Latest Developments
11.4 Abilify Maintena
11.4.1 Abilify Maintena Company Information
11.4.2 Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.4.3 Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Abilify Maintena Main Business Overview
11.4.5 Abilify Maintena Latest Developments
11.5 Haldol
11.5.1 Haldol Company Information
11.5.2 Haldol Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.5.3 Haldol Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Haldol Main Business Overview
11.5.5 Haldol Latest Developments
11.6 Otsuka Pharmaceutical
11.6.1 Otsuka Pharmaceutical Company Information
11.6.2 Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.6.3 Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Otsuka Pharmaceutical Main Business Overview
11.6.5 Otsuka Pharmaceutical Latest Developments
11.7 Aristada
11.7.1 Aristada Company Information
11.7.2 Aristada Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.7.3 Aristada Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Aristada Main Business Overview
11.7.5 Aristada Latest Developments
11.8 Prolixin
11.8.1 Prolixin Company Information
11.8.2 Prolixin Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.8.3 Prolixin Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Prolixin Main Business Overview
11.8.5 Prolixin Latest Developments
11.9 Sumitomo Dainippon Pharma
11.9.1 Sumitomo Dainippon Pharma Company Information
11.9.2 Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.9.3 Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sumitomo Dainippon Pharma Main Business Overview
11.9.5 Sumitomo Dainippon Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Size (2021-2032)
2.1.2 Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Long-Acting Injectable (LAI) Antipsychotic by Country/Region (2021, 2025 & 2032)
2.2 Long-Acting Injectable (LAI) Antipsychotic Segment by Type
2.2.1 Aripiprazole
2.2.2 Fluphenazine
2.2.3 Haloperidol
2.2.4 Others
2.2.5 Long-Acting Injectable (LAI) Antipsychotic Market Size by Type
2.2.5.1 Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
2.3 Long-Acting Injectable (LAI) Antipsychotic Segment by Application
2.3.1 Hospital
2.3.2 Retail Pharmacy
2.3.3 Others
2.3.4 Long-Acting Injectable (LAI) Antipsychotic Market Size by Application
2.3.4.1 Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
3 LONG-ACTING INJECTABLE (LAI) ANTIPSYCHOTIC MARKET SIZE BY PLAYER
3.1 Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Player
3.1.1 Global Long-Acting Injectable (LAI) Antipsychotic Revenue by Player (2021-2026)
3.1.2 Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Player (2021-2026)
3.2 Global Long-Acting Injectable (LAI) Antipsychotic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LONG-ACTING INJECTABLE (LAI) ANTIPSYCHOTIC BY REGION
4.1 Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2021-2026)
4.2 Global Long-Acting Injectable (LAI) Antipsychotic Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-Acting Injectable (LAI) Antipsychotic Market Size Growth (2021-2026)
4.4 APAC Long-Acting Injectable (LAI) Antipsychotic Market Size Growth (2021-2026)
4.5 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Growth (2021-2026)
4.6 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2021-2026)
5.2 Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026)
5.3 Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2021-2026)
6.2 APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026)
6.3 APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2021-2026)
7.2 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026)
7.3 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic by Region (2021-2026)
8.2 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026)
8.3 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LONG-ACTING INJECTABLE (LAI) ANTIPSYCHOTIC MARKET FORECAST
10.1 Global Long-Acting Injectable (LAI) Antipsychotic Forecast by Region (2027-2032)
10.1.1 Global Long-Acting Injectable (LAI) Antipsychotic Forecast by Region (2027-2032)
10.1.2 Americas Long-Acting Injectable (LAI) Antipsychotic Forecast
10.1.3 APAC Long-Acting Injectable (LAI) Antipsychotic Forecast
10.1.4 Europe Long-Acting Injectable (LAI) Antipsychotic Forecast
10.1.5 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Forecast
10.2 Americas Long-Acting Injectable (LAI) Antipsychotic Forecast by Country (2027-2032)
10.2.1 United States Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.2.2 Canada Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.2.3 Mexico Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.2.4 Brazil Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.3 APAC Long-Acting Injectable (LAI) Antipsychotic Forecast by Region (2027-2032)
10.3.1 China Long-Acting Injectable (LAI) Antipsychotic Market Forecast
10.3.2 Japan Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.3.3 Korea Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.3.4 Southeast Asia Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.3.5 India Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.3.6 Australia Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.4 Europe Long-Acting Injectable (LAI) Antipsychotic Forecast by Country (2027-2032)
10.4.1 Germany Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.4.2 France Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.4.3 UK Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.4.4 Italy Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.4.5 Russia Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.5 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Forecast by Region (2027-2032)
10.5.1 Egypt Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.5.2 South Africa Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.5.3 Israel Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.5.4 Turkey Market Long-Acting Injectable (LAI) Antipsychotic Forecast
10.6 Global Long-Acting Injectable (LAI) Antipsychotic Forecast by Type (2027-2032)
10.7 Global Long-Acting Injectable (LAI) Antipsychotic Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Long-Acting Injectable (LAI) Antipsychotic Forecast
11 KEY PLAYERS ANALYSIS
11.1 Alkermes
11.1.1 Alkermes Company Information
11.1.2 Alkermes Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.1.3 Alkermes Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Alkermes Main Business Overview
11.1.5 Alkermes Latest Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Information
11.2.2 Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.2.3 Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Eli Lilly and Company Main Business Overview
11.2.5 Eli Lilly and Company Latest Developments
11.3 Janssen Global Services, LLC
11.3.1 Janssen Global Services, LLC Company Information
11.3.2 Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.3.3 Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Janssen Global Services, LLC Main Business Overview
11.3.5 Janssen Global Services, LLC Latest Developments
11.4 Abilify Maintena
11.4.1 Abilify Maintena Company Information
11.4.2 Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.4.3 Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Abilify Maintena Main Business Overview
11.4.5 Abilify Maintena Latest Developments
11.5 Haldol
11.5.1 Haldol Company Information
11.5.2 Haldol Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.5.3 Haldol Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Haldol Main Business Overview
11.5.5 Haldol Latest Developments
11.6 Otsuka Pharmaceutical
11.6.1 Otsuka Pharmaceutical Company Information
11.6.2 Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.6.3 Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Otsuka Pharmaceutical Main Business Overview
11.6.5 Otsuka Pharmaceutical Latest Developments
11.7 Aristada
11.7.1 Aristada Company Information
11.7.2 Aristada Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.7.3 Aristada Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Aristada Main Business Overview
11.7.5 Aristada Latest Developments
11.8 Prolixin
11.8.1 Prolixin Company Information
11.8.2 Prolixin Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.8.3 Prolixin Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Prolixin Main Business Overview
11.8.5 Prolixin Latest Developments
11.9 Sumitomo Dainippon Pharma
11.9.1 Sumitomo Dainippon Pharma Company Information
11.9.2 Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Product Offered
11.9.3 Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Sumitomo Dainippon Pharma Main Business Overview
11.9.5 Sumitomo Dainippon Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Long-Acting Injectable (LAI) Antipsychotic Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Aripiprazole
Table 4. Major Players of Fluphenazine
Table 5. Major Players of Haloperidol
Table 6. Major Players of Others
Table 7. Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
Table 10. Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
Table 13. Global Long-Acting Injectable (LAI) Antipsychotic Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Player (2021-2026)
Table 15. Long-Acting Injectable (LAI) Antipsychotic Key Players Head office and Products Offered
Table 16. Long-Acting Injectable (LAI) Antipsychotic Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Region (2021-2026)
Table 21. Global Long-Acting Injectable (LAI) Antipsychotic Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Country (2021-2026)
Table 25. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
Table 27. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
Table 29. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Region (2021-2026)
Table 31. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Country (2021-2026)
Table 35. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Long-Acting Injectable (LAI) Antipsychotic
Table 41. Key Market Challenges & Risks of Long-Acting Injectable (LAI) Antipsychotic
Table 42. Key Industry Trends of Long-Acting Injectable (LAI) Antipsychotic
Table 43. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Alkermes Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 48. Alkermes Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 49. Alkermes Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Alkermes Main Business
Table 51. Alkermes Latest Developments
Table 52. Eli Lilly and Company Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 53. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 54. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Eli Lilly and Company Main Business
Table 56. Eli Lilly and Company Latest Developments
Table 57. Janssen Global Services, LLC Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 58. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 59. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Janssen Global Services, LLC Main Business
Table 61. Janssen Global Services, LLC Latest Developments
Table 62. Abilify Maintena Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 63. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 64. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Abilify Maintena Main Business
Table 66. Abilify Maintena Latest Developments
Table 67. Haldol Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 68. Haldol Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 69. Haldol Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Haldol Main Business
Table 71. Haldol Latest Developments
Table 72. Otsuka Pharmaceutical Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 73. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 74. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Otsuka Pharmaceutical Main Business
Table 76. Otsuka Pharmaceutical Latest Developments
Table 77. Aristada Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 78. Aristada Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 79. Aristada Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Aristada Main Business
Table 81. Aristada Latest Developments
Table 82. Prolixin Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 83. Prolixin Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 84. Prolixin Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Prolixin Main Business
Table 86. Prolixin Latest Developments
Table 87. Sumitomo Dainippon Pharma Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 88. Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 89. Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Sumitomo Dainippon Pharma Main Business
Table 91. Sumitomo Dainippon Pharma Latest Developments
Table 1. Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Long-Acting Injectable (LAI) Antipsychotic Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Aripiprazole
Table 4. Major Players of Fluphenazine
Table 5. Major Players of Haloperidol
Table 6. Major Players of Others
Table 7. Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
Table 10. Long-Acting Injectable (LAI) Antipsychotic Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
Table 13. Global Long-Acting Injectable (LAI) Antipsychotic Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Player (2021-2026)
Table 15. Long-Acting Injectable (LAI) Antipsychotic Key Players Head office and Products Offered
Table 16. Long-Acting Injectable (LAI) Antipsychotic Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Region (2021-2026)
Table 21. Global Long-Acting Injectable (LAI) Antipsychotic Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Country (2021-2026)
Table 25. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
Table 27. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
Table 29. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Region (2021-2026)
Table 31. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Country (2021-2026)
Table 35. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Long-Acting Injectable (LAI) Antipsychotic
Table 41. Key Market Challenges & Risks of Long-Acting Injectable (LAI) Antipsychotic
Table 42. Key Industry Trends of Long-Acting Injectable (LAI) Antipsychotic
Table 43. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Alkermes Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 48. Alkermes Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 49. Alkermes Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Alkermes Main Business
Table 51. Alkermes Latest Developments
Table 52. Eli Lilly and Company Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 53. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 54. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Eli Lilly and Company Main Business
Table 56. Eli Lilly and Company Latest Developments
Table 57. Janssen Global Services, LLC Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 58. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 59. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Janssen Global Services, LLC Main Business
Table 61. Janssen Global Services, LLC Latest Developments
Table 62. Abilify Maintena Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 63. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 64. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Abilify Maintena Main Business
Table 66. Abilify Maintena Latest Developments
Table 67. Haldol Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 68. Haldol Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 69. Haldol Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Haldol Main Business
Table 71. Haldol Latest Developments
Table 72. Otsuka Pharmaceutical Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 73. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 74. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Otsuka Pharmaceutical Main Business
Table 76. Otsuka Pharmaceutical Latest Developments
Table 77. Aristada Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 78. Aristada Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 79. Aristada Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Aristada Main Business
Table 81. Aristada Latest Developments
Table 82. Prolixin Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 83. Prolixin Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 84. Prolixin Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Prolixin Main Business
Table 86. Prolixin Latest Developments
Table 87. Sumitomo Dainippon Pharma Details, Company Type, Long-Acting Injectable (LAI) Antipsychotic Area Served and Its Competitors
Table 88. Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Product Offered
Table 89. Sumitomo Dainippon Pharma Long-Acting Injectable (LAI) Antipsychotic Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Sumitomo Dainippon Pharma Main Business
Table 91. Sumitomo Dainippon Pharma Latest Developments
LIST OF FIGURES
Figure 1. Long-Acting Injectable (LAI) Antipsychotic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Long-Acting Injectable (LAI) Antipsychotic Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Long-Acting Injectable (LAI) Antipsychotic Sales Market Share by Country/Region (2025)
Figure 8. Long-Acting Injectable (LAI) Antipsychotic Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type in 2025
Figure 10. Long-Acting Injectable (LAI) Antipsychotic in Hospital
Figure 11. Global Long-Acting Injectable (LAI) Antipsychotic Market: Hospital (2021-2026) & ($ millions)
Figure 12. Long-Acting Injectable (LAI) Antipsychotic in Retail Pharmacy
Figure 13. Global Long-Acting Injectable (LAI) Antipsychotic Market: Retail Pharmacy (2021-2026) & ($ millions)
Figure 14. Long-Acting Injectable (LAI) Antipsychotic in Others
Figure 15. Global Long-Acting Injectable (LAI) Antipsychotic Market: Others (2021-2026) & ($ millions)
Figure 16. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application in 2025
Figure 17. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Player in 2025
Figure 18. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Region (2021-2026)
Figure 19. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size 2021-2026 ($ millions)
Figure 20. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size 2021-2026 ($ millions)
Figure 21. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size 2021-2026 ($ millions)
Figure 23. Americas Long-Acting Injectable (LAI) Antipsychotic Value Market Share by Country in 2025
Figure 24. United States Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Region in 2025
Figure 29. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
Figure 30. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
Figure 31. China Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 35. India Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Country in 2025
Figure 38. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
Figure 39. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
Figure 40. Germany Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 41. France Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 54. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 55. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 57. United States Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 58. Canada Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 59. Mexico Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 60. Brazil Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 61. China Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 62. Japan Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 63. Korea Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 65. India Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 66. Australia Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 67. Germany Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 68. France Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 69. UK Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 70. Italy Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 71. Russia Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 72. Egypt Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 73. South Africa Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 74. Israel Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 75. Turkey Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 76. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 1. Long-Acting Injectable (LAI) Antipsychotic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Long-Acting Injectable (LAI) Antipsychotic Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Long-Acting Injectable (LAI) Antipsychotic Sales Market Share by Country/Region (2025)
Figure 8. Long-Acting Injectable (LAI) Antipsychotic Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type in 2025
Figure 10. Long-Acting Injectable (LAI) Antipsychotic in Hospital
Figure 11. Global Long-Acting Injectable (LAI) Antipsychotic Market: Hospital (2021-2026) & ($ millions)
Figure 12. Long-Acting Injectable (LAI) Antipsychotic in Retail Pharmacy
Figure 13. Global Long-Acting Injectable (LAI) Antipsychotic Market: Retail Pharmacy (2021-2026) & ($ millions)
Figure 14. Long-Acting Injectable (LAI) Antipsychotic in Others
Figure 15. Global Long-Acting Injectable (LAI) Antipsychotic Market: Others (2021-2026) & ($ millions)
Figure 16. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application in 2025
Figure 17. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Market Share by Player in 2025
Figure 18. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Region (2021-2026)
Figure 19. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size 2021-2026 ($ millions)
Figure 20. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size 2021-2026 ($ millions)
Figure 21. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size 2021-2026 ($ millions)
Figure 23. Americas Long-Acting Injectable (LAI) Antipsychotic Value Market Share by Country in 2025
Figure 24. United States Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Region in 2025
Figure 29. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
Figure 30. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
Figure 31. China Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 35. India Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Country in 2025
Figure 38. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
Figure 39. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
Figure 40. Germany Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 41. France Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Long-Acting Injectable (LAI) Antipsychotic Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 54. APAC Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 55. Europe Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 57. United States Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 58. Canada Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 59. Mexico Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 60. Brazil Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 61. China Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 62. Japan Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 63. Korea Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 65. India Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 66. Australia Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 67. Germany Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 68. France Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 69. UK Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 70. Italy Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 71. Russia Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 72. Egypt Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 73. South Africa Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 74. Israel Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 75. Turkey Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
Figure 76. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Long-Acting Injectable (LAI) Antipsychotic Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Long-Acting Injectable (LAI) Antipsychotic Market Size 2027-2032 ($ millions)
